News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News EuroPCR 2025 Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI Michael O'Riordan May 23, 2025
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Conference News STS 2022 Acute Type A Aortic Dissection Repair Outcomes Didn’t Suffer in Early COVID-19 Todd Neale February 01, 2022
News Daily News Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD L.A. McKeown November 04, 2021
News Daily News SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR Todd Neale October 22, 2018
News Conference News The Structural Heart Disease Summit 2018 SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications Michael O'Riordan June 23, 2018
News Daily News TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher L.A. McKeown May 11, 2018
News Industry News First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure May 02, 2018
News Daily News Recent Stroke Heightens Risk of Perioperative Events After AVR Todd Neale April 25, 2018
News Conference News ISET 2018 Next-Generation Large-Bore Closure Devices Arrive Caitlin E. Cox February 05, 2018
Manuscript Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study January 03, 2018
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Daily News New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk Todd Neale September 29, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Daily News Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases Todd Neale July 14, 2016